Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-18

Clinical Trial Update: T2DXcel Mobile Application [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial update for the T2DXcel mobile application in adults with Type 2 diabetes; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • T2DXcel

Snippet

Sponsor: Montefiore Medical Center | Conditions: Diabetes Mellitus, Type 2 | Phase 1, Phase 2 | Status: COMPLETED